Paper22326673
Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.
Liu SH and 1 other. J Ethnopharmacol, 2012. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. Papers, record 22326673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22326673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Drug-Related Side Effects and Adverse Reactions | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Magnoliopsida | Major topic |
| Neoplasms | Major topic |
| Phytotherapy | Major topic |
| Plants, Medicinal | Major topic |
| Animals | |
| Chemotherapy, Adjuvant | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1P01CA154295-01 | NCI NIH HHS | United States | P01CA154295 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04000737 | YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) | Background |
Source ClinicalTrials.gov
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41696740 | Huang-qin decoction increases the sensitivity of EGFR-TKIs to NSCLC cells by regulating stat3/GPX4 to induce redox ratio and ROS to inhibit CSCs. | J Tradit Complement Med | 2026 | https://conductscience.org/library/papers/41696740 | PubMed |
| 40978061 | The advantages of TCM in the treatment of gynecologic malignancies. | Front Oncol | 2025 | https://conductscience.org/library/papers/40978061 | PubMed |
| 40732339 | Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Huang Qin Decoction Preventing Colorectal Cancer Liver Metastasis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732339 | PubMed |
| 39996849 | Areca catechu L. Extract Inhibits Colorectal Cancer Tumor Growth by Modulating Cell Apoptosis and Autophagy. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/39996849 | PubMed |
| 39696809 | Exploration of In Situ Extraction for Enhanced Triterpenoid Production by Saccharomyces cerevisiae. | Microb Biotechnol | 2024 | https://conductscience.org/library/papers/39696809 | PubMed |
| 39691196 | Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment. | Heliyon | 2024 | https://conductscience.org/library/papers/39691196 | PubMed |
| 39354529 | Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39354529 | PubMed |
| 39139999 | Baicalin reduces chronic stress-induced breast cancer metastasis via directly targeting β2-adrenergic receptor. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39139999 | PubMed |
| 38956673 | An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer. | Chin Med | 2024 | https://conductscience.org/library/papers/38956673 | PubMed |
| 38814918 | Harnessing controlled-environment systems for enhanced production of medicinal plants. | J Exp Bot | 2025 | https://conductscience.org/library/papers/38814918 | PubMed |
| 38791314 | Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791314 | PubMed |
| 38375031 | The effective combination therapies with irinotecan for colorectal cancer. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38375031 | PubMed |
| 38232757 | Evidence and possible mechanism of Scutellaria baicalensis and its bioactive compounds for hepatocellular carcinoma treatment. | Ann Med | 2023 | https://conductscience.org/library/papers/38232757 | PubMed |
| 38099482 | Current Characteristics of Herbal Medicine Interventions for Cancer on Clinical Databases: A Cross-Sectional Study. | Integr Cancer Ther | 2023 | https://conductscience.org/library/papers/38099482 | PubMed |
| 38079061 | Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer - An Overview. | Curr Treat Options Oncol | 2023 | https://conductscience.org/library/papers/38079061 | PubMed |
| 37664157 | Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37664157 | PubMed |
| 37592799 | Herbal Medicines as Adjuvants for the Treatment of Chemotherapy-Induced Diarrhea. | Curr Drug Metab | 2023 | https://conductscience.org/library/papers/37592799 | PubMed |
| 37242514 | Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242514 | PubMed |
| 36686648 | YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36686648 | PubMed |
| 36440293 | East Wind, West Wind: Toward the modernization of traditional Chinese medicine. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36440293 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22326673
GET https://conductscience.org/api/papers/v1/22326673/cited_by?page=2